Peptide receptors in gut endocrine tumours

Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

1973 • 3,509 citations

Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1993 • 1,563 citations

Octreotide

1996 • 956 citations

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1992 • 948 citations

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1991 • 827 citations

Classification and nomenclature of somatostatin receptors

1995 • 573 citations

N‐terminally extended somatostatin: The primary structure of somatostatin‐28

1980 • 516 citations

Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.

1990 • 374 citations

Cytoreductive hepatic surgery for neuroendocrine tumors.

1990 • 373 citations

Radiotherapy with a Radiolabeled Somatostatin Analogue, [¹¹¹In‐DTPA‐<scp>d</scp>‐Phe¹]‐Octreotide

1994 • 300 citations

Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms.

1995 • 300 citations

The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas

1994 • 293 citations

Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase.

1989 • 288 citations

Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization

1995 • 286 citations

The Role of Somatostatin in the Regulation of Anterior Pituitary Hormone Secretion and the Use of Its Analogs in the Treatment of Human Pituitary Tumors

1988 • 271 citations

Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.

1994 • 271 citations

Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors

1994 • 258 citations

Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications

1992 • 224 citations

Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth

1991 • 222 citations

Neuropeptide receptors in health and disease: the molecular basis for in vivo imaging.

1995 • 198 citations

Substance‐P receptors in human primary neoplasms: Tumoral and vascular localization

1995 • 196 citations

Parallelin Vivoandin VitroDetection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis, Localization, and Therapy

1990 • 196 citations

Somatostatin analogue scintigraphy in carcinoid tumours

1993 • 182 citations

Somatostatin‐receptor Scintigraphy in Gastroenteropancreatic Tumors

1994 • 163 citations

Somatostatin and the immune and haematopoetic system; a review

1994 • 162 citations

Molecular properties of somatostatin receptors

1995 • 162 citations

In vitro identification of vasoactive intestinal peptide receptors in human tumors: implications for tumor imaging.

1995 • 140 citations

Multiple actions of somatostatin in neoplastic disease

1995 • 128 citations

High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction?

1994 • 123 citations

Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management.

1995 • 116 citations

Evaluation of Receptors for Somatostatin in Various Tumors Using Different Analogs*

1990 • 113 citations

[111In-DTPA-D-Phe1]Octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

1994 • 111 citations

Expression of Somatostatin Receptors in Normal, Inflamed, and Neoplastic Human Gastrointestinal Tissues

1994 • 110 citations

Cell Cycle Dependent Induction of Apoptosis by Somatostatin Analog SMS 201-995 in AtT-20 Mouse Pituitary Cells

1995 • 99 citations

Internalization of the radioiodinated somatostatin analog [125I-Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide.

1995 • 98 citations

In vitro detection of somatostatin receptors in human tumors

1992 • 93 citations

Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma.

1995 • 77 citations

Intraoperative localization of neuroendocrine tumors with 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe.

1993 • 73 citations

Vasoactive intestinal peptide receptor scintigraphy.

1995 • 71 citations

Somatostatin receptors and disease: Role of receptor subtypes

1996 • 70 citations

The Use of Chemotherapy in the Management of Neuroendocrine Tumors

1993 • 69 citations

Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells.

1994 • 52 citations

Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes

1995 • 48 citations

Octreotide and Related Somatostatin Analogs in the Diagnosis and Treatment of Pituitary Disease and Somatostatin Receptor Scintigraphy

1993 • 48 citations

Development of resistance to a long-acting somatostatin analogue during treatment of two patients with metastatic endocrine pancreatic tumours

1988 • 38 citations

Vasoactive intestinal peptide receptor scintigraphy

1996 • 37 citations

The Clinical Use of Interferons in the Management of Neuroendocrine Gastroenteropancreatic Tumors

1994 • 34 citations

Growth Regulation in Carcinoid Tumors

1993 • 29 citations

Expression of somatostatin receptor subtypes in breast carcinoma, carcinoid tumor, and renal cell carcinoma

1995 • 26 citations

Internalization of the radioiodinated somatostatin analog [125I- Tyr3]octreotide by mouse and human pituitary tumor cells: increase by unlabeled octreotide

1995 • 22 citations

Unexpected growth-stimulatory effect of somatostatin analogue on cultured human pancreatic carcinoid cells

1992 • 21 citations

Somatostatin Receptor Scintigraphy

2011 • 21 citations

Relative potencies of the somatostatin analogs octreotide, BIM-23014, and RC-160 on the inhibition of hormone release by cultured human endocrine tumor cells and normal rat anterior pituitary cells

1994 • 18 citations

The Role of Peptides and their Receptors as Tumor Markers

1993 • 16 citations

A case of antibody formation against octreotide visualized with ¹¹¹In‐octreotide scintigraphy

1993 • 9 citations

Overview of European Results

2008 • 1 citations

Deleted Work

1955 • 0 citations